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AbstrACt
Introduction Robotic-assisted surgery (RAS) has emerged 
as an alternative minimally invasive surgical option. 
Despite its growing applicability, the frequent need for 
pneumoperitoneum and Trendelenburg position could 
significantly affect respiratory mechanics during RAS. 
AVATaR is an international multicenter observational study 
aiming to assess the incidence of postoperative pulmonary 
complications (PPC), to characterise current practices of 
mechanical ventilation (MV) and to evaluate a possible 
association between ventilatory parameters and PPC in 
patients undergoing RAS.
Methods and analysis AVATaR is an observational study of 
surgical patients undergoing MV for general anaesthesia for 
RAS. The primary outcome is the incidence of PPC during the 
first five postoperative days. Secondary outcomes include 
practice of MV, effect of surgical positioning on MV, effect of 
MV on clinical outcome and intraoperative complications.
Ethics and dissemination This study was approved by 
the Institutional Review Board of the Hospital Israelita Albert 
Einstein. The study results will be published in peer-reviewed 
journals and disseminated at international conferences.
trial registration number NCT02989415; Pre-results.
IntroduCtIon 
Minimally invasive surgery is increasingly 
being used due to its association with reduced 
surgical trauma and postoperative pain, low 
bleeding complication rates, shorter hospital 
length of stay and increased patient satisfac-
tion.1 2 Robotic-assisted surgery (RAS) has 
emerged as an alternative minimally inva-
sive surgical option, providing increased 
strengths and limitations of this study
 ► This will be the first study to assess the incidence 
of postoperative pulmonary complications and the 
ventilatory practice in patients undergoing general 
anaesthesia for robotic surgery.
 ► This is a multinational, multicenter, prospective, 
observational, rather than retrospective, study and 
should enhance our understanding of the incidence 
of postoperative pulmonary complications and the 
ventilatory practice in this group of patients.
 ► Ventilatory variables will be measured at the critical 
points of the surgery, to assess the impact of sur-
gical positioning and of the pneumoperitoneum in 
respiratory mechanics.
 ► Due to the absence of standardisation on the defi-
nition of postoperative pulmonary complications, 
some complications will not be addressed.
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ergonomics, magnification of the surgical field, greater 
amplitude of movement and higher precision.3 
Despite the growing applicability of RAS, the need 
of pneumoperitoneum and steep head-down (Trende-
lenburg) position could have a marked influence on 
patients respiratory mechanics. Indeed, this could lead 
to increased intra-abdominal pressure and cephalic eleva-
tion of the diaphragm, decreasing the compliance of the 
respiratory system and tidal volume, as well as increasing 
the plateau and peak pressure.4–8
Postoperative pulmonary complication (PPC) usually 
occur between 5 and 7 days after surgery and include the 
development of respiratory events, such as acute respira-
tory failure, acute respiratory distress syndrome (ARDS), 
pneumonia, prolonged or unplanned mechanical venti-
lation, reintubation, hypoxemia, atelectasis, broncho-
spasm, pleural effusion, pneumothorax and respiratory 
depression.9 Approximately, 5% of patients submitted to 
surgery develop at least one PPC during the follow-up, 
resulting in longer hospital length of stay and higher 
mortality rates.10 The changes in respiratory mechanics 
induced by the surgical positioning and by the degree of 
pneumoperitoneum during RAS could increase the risk 
of PPC in this group of patients. Nevertheless, there are 
currently insufficient data to guide the best ventilatory 
strategy during RAS, with some reports suggesting that 
ventilatory parameters should be adjusted to maintain 
normocapnia, despite the associated need for high tidal 
volumes.8 11
The aim of the AVATaR study is to investigate the inci-
dence of PPC, characterise current ventilatory practices 
and evaluate the association between ventilatory param-
eters and outcomes in surgical patients undergoing 
general anaesthesia for RAS.
MEthods
design
This is an international multicenter prospective observa-
tional study designed in accordance with the declaration 
of Helsinki, registered at www. clinicaltrials. gov (trial iden-
tification number NCT02989415).
Patient and public involvement
Patients or public were not involved in the study design.
Patient eligibility
Consecutive patients undergoing mechanical ventilation 
for general anaesthesia for RAS will be consecutively 
included during a period of 1 month, to be defined by 
each of the participating centres. The need for informed 
consent is determined by the Institutional Review Board 
of each participating centre or country, following local 
regulations.
Inclusion and exclusion criteria
Patients fulfilling the following inclusion criteria are 
included: (1) age ≥18 years and (2) surgical procedures 
performed under general anaesthesia for RAS, including 
head and neck, chest, cardiac and abdominal surgeries. 
Patients submitted to procedures during pregnancy or 
outside the operation room are excluded.
steps and data collection
Local investigators at each participating centres screen 
all patients submitted to mechanical ventilation during 
general anaesthesia for RAS during a predefined period 
of 1 month. PPC will be collected on day 0 (end of surgery 
until 11:59 pm) and on postoperative days 1, 2, 3, 4 and 
5 (each day goes from 00:00 to 23:59). Data collection 
is finished on the day of hospital discharge or on day 5, 
for patients who remain hospitalised (figure 1). The start 
date for each participating centre is flexible and is deter-
mined together with the study coordinator.
outcomes
The primary outcome is the incidence of PPC, defined 
as a collapse composite endpoint of: unplanned need 
for oxygen therapy (defined as supplementary oxygen 
used due to PaO2 <60 mm Hg or SpO2 <92% in room 
air in individuals with no prior pulmonary disease or 
SpO2 <88% in individuals with prior pulmonary disease), 
development of acute respiratory failure (defined as PaO2 
<60 mm Hg or SpO2 <92%, despite treatment with oxygen 
or need for non-invasive ventilation or unplanned contin-
uous mechanical ventilation), development of pneu-
monia (defined by the presence of a new or progressive 
radiographic infiltrate in addition to at least two of the 
five clinical characteristics: fever >38°C, leucocytosis or 
leucopenia (leucocyte counte > 12.0 x 10^9/L or < 4.0 x 
10^9/L, respectively),12 development of ARDS (defined 
according to Berlin criteria)13 and/or development of 
Figure 1 Study flow chart.
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pneumothorax (defined as the presence of air between 
the visceral and parietal pleura; diagnosis can be made by 
clinical examination and chest X-ray).14
Secondary outcomes include practice of ventila-
tion, severe PPC (excluding the unplanned need for 
oxygen), intraoperative complications (including 
desaturation (SpO2 <92% for 3 min or more), need for 
unplanned recruitment manoeuvres, need for venti-
latory pressure reduction, hypotension (defined as 
systolic blood pressure <90 mm Hg or mean arterial 
Table 1 Characteristics of the included patients
All patients (n=)
Age, years Mean±SD
Male sex n/Total (%)
BMI, kg/m2 Mean±SD
ASA Mean±SD
  1 n/Total (%)
  2 n/Total (%)
  3 n/Total (%)
  4 n/Total (%)
  5 n/Total (%)
ARISCAT Mean±SD
  <26 n/Total (%)
  26–44 n/Total (%)
  ≥45 n/Total (%)
Functional status
  Independent n/Total (%)
  Partially dependent n/Total (%)
  Totally dependent n/Total (%)
Comorbidities
  Hypertension n/Total (%)
  Coronary disease n/Total (%)
  Atrial fibrillation/flutter n/Total (%)
  Heart failure n/Total (%)
  Diabetes mellitus n/Total (%)
  COPD n/Total (%)
  Asthma n/Total (%)
  Smoking n/Total (%)
  Obstructive sleep apnoea n/Total (%)
  Active neoplasia n/Total (%)
  Liver cirrhosis n/Total (%)
  Anaemia (Hb <10 g/dL) n/Total (%)
  Chronic kidney disease n/Total (%)
  Haematological disease n/Total (%)
  Use of immunosuppression n/Total (%)
Complications≤30 days before surgery
  None n/Total (%)
  Respiratory infection n/Total (%)
  Use of mechanical ventilation n/Total (%)
  Transfusion of blood products n/Total (%)
Vital signs
  Respiratory rate, mpm Mean±SD
  Heart rate, bpm Mean±SD
  Mean arterial pressure, mm Hg Mean±SD
  SpO2, % Mean±SD
Laboratory tests
  Haemoglobin, g/dL Mean±SD
Continued
All patients (n=)
  Leucocytes, x10^9/L Mean±SD
  Creatinine, mg/dL Mean±SD
Condition of the procedure
  Elective n/Total (%)
  Urgency n/Total (%)
  Emergency n/Total (%)
Expected duration of surgery
  ≤2 hours n/Total (%)
  2–3 hours n/Total (%)
  >3 hours n/Total (%)
Incision
  Peripheral n/Total (%)
  Low abdomen n/Total (%)
  High abdomen n/Total (%)
  Intrathoracic n/Total (%)
  Other n/Total (%)
Surgical procedure
  Prostatectomy n/Total (%)
  Nephrectomy n/Total (%)
  Hysterectomy n/Total (%)
  Bariatric n/Total (%)
  Sacrocolpopexy n/Total (%)
  Cholecystectomy n/Total (%)
  Cardiac n/Total (%)
  Colorectal n/Total (%)
  Hernia n/Total (%)
  Head and neck n/Total (%)
  Pulmonary resection n/Total (%)
  Cystectomy n/Total (%)
  Pyloropasty n/Total (%)
  Pyeloplasty n/Total (%)
  Other n/Total (%)
ARISCAT, assess respiratory risk in surgical patients in Catalonia; 
ASA, American Society of Anesthesiology; BMI, body mass index; 
bpm, beats per minute; COPD, chronic obstructive pulmonary 
disease; Hb, haemoglobin; mpm, movements per minute; 
SpO2, pulse oximetry.
Table 1 Continued 
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pressure <65 mm Hg for 3 min or more or need of vaso-
active drugs for correction), need for unplanned vaso-
active drugs (need for vasoactive drugs not planned 
before and/or continuous infusion) and/or acute 
new arrhythmia (atrial fibrillation, sustained ventric-
ular tachycardia, supraventricular tachycardia and/or 
ventricular fibrillation)), need for unplanned mechan-
ical ventilation after surgery (including reintubation), 
need for intensive care unit admission, hospital length 
of stay and hospital mortality.
study organisation
The steering committee includes the principal investi-
gator, the coordinating investigator and experts in ventila-
tory support in surgical patients, all of whom contributed 
to the design and revisions of the original study protocol. 
The coordinating investigator is responsible for adminis-
trative management and communication with the local 
investigators and provided assistance to the participating 
clinical sites in study management, record keeping and 
data management. Local investigators provided structural 
and scientific leadership. They guaranteed the integrity 
of data collection and ensure timely completion of the 
case report forms.
data collection
Data collection is performed using electronic case 
report form in the Research Electronic Data Capture 
(REDCap, USA) via the Internet at the Clinical Research 
Unit system of the Hospital Israelita Albert Einstein 
(the case report form is available in the online Supple-
mentary data). The system has the following functions: 
patient registration, data input, data cleaning, audit 
trail and data export for statistical analysis. Local inves-
tigators enter the data directly into the system. Instruc-
tions for using the system are available to investigators 
at all times. Electronic files are archived in the Hospital 
Israelita Albert Einstein-based server in a secure and 
controlled environment to maintain confidentiality. 
Electronic documents are controlled with password 
protection according to best practices.
data management
The goal of the clinical data management plan is to 
provide high–quality data by adopting standardised 
Table 2 Intraoperative characteristics
All patients (n=)
Type of tracheal tube
  Simple endotracheal n/Total (%)
  Double-lumen endotracheal n/Total (%)
  Nasotracheal n/Total (%)
  Endobronchial tube n/Total (%)
  Endobrochial blocker n/Total (%)
Type of anaesthesia
  Total intravenous n/Total (%)
  Volatile n/Total (%)
  Balanced n/Total (%)
Use of antibiotic prophylaxis n/Total (%)
Use of one-lung ventilation n/Total (%)
  Left lung ventilated n/Total (%)
  Right lung ventilated n/Total (%)
Use of neuroaxial blockade n/Total (%)
  Epidural n/Total (%)
  Spinal n/Total (%)
  Combined n/Total (%)
Use of Trendelenburg during surgery n/Total (%)
  Normal n/Total (%)
  Accentuated (≥40° of the bed) n/Total (%)
  Reverse n/Total (%)
Surgical conversion n/Total (%)
  Conversion to open surgery n/Total (%)
  Conversion to laparoscopic n/Total (%)
Use of carbondioxide insufflation n/Total (%)
  Abdominal n/Total (%)
  Thoracic n/Total (%)
  Mediastinum n/Total (%)
Use of opioids n/Total (%)
  Short acting n/Total (%)
  Long acting n/Total (%)
  Both n/Total (%)
Use of neuromuscular blocking agents n/Total (%)
Neuromuscular blockade monitoring n/Total (%)
Reversal of neuromuscular blockade n/Total (%)
Residual curarisation n/Total (%)
Total fluid intake, mL Mean±SD
  Crystalloids, mL Mean±SD
  Synthetic colloid, mL Mean±SD
  Albumin, mL Mean±SD
Urine output, mL Mean±SD
Blood loss, mL Mean±SD
Fluid balance, mL Mean±SD
Temperature at the end of the surgery, °C Mean±SD
Continued
All patients (n=)
Transfusion of blood products n/Total (%)
  Red blood cells n/Total (%)
  Fresh frozen plasma n/Total (%)
  Platelets n/Total (%)
  Cryoprecipitate n/Total (%)
Duration of surgery, min Mean±SD
Duration of anaesthesia, min Mean±SD
Table 2 Continued 
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procedures to minimise the number of errors and missing 
data, and consequently, to generate an accurate database 
for analysis. Remote monitoring is performed to signal 
early aberrant patterns, issues with consistency, credibility 
and other anomalies, according to predefined queries 
created in the system. Any missing and outlier data values 
are individually revised and completed or corrected 
whenever possible.
Table 3 Intraoperative ventilation in four specific periods
Five minutes 
after induction 
and beginning of 
ventilation
Five minutes after 
CO2 insufflation
Five minutes after 
definitive positioning
Five minutes after 
desinsufflation and 
return to supine
Patients P values Patients
P 
values Patients P values Patients P values
Surgical positioning
  Dorsal decubitus n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  Ventral decubitus n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  Lateral decubitus n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  Lithotomy n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  Trendelenburg n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  Reverse Trendelenburg n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  Sitting n/Total (%) n/Total (%) n/Total (%) n/Total (%)
Mode of ventilation
  Pressure controlled n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  Volume controlled n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  PCVG n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  Other n/Total (%) n/Total (%) n/Total (%) n/Total (%)
Peak pressure, cmH2O Mean±SD Mean±SD Mean±SD Mean±SD
Plateau pressure, cmH2O Mean±SD Mean±SD Mean±SD Mean±SD
Driving pressure, cmH2O Mean±SD Mean±SD Mean±SD Mean±SD
PEEP, cmH2O Mean±SD Mean±SD Mean±SD Mean±SD
Tidal volume, mL/kg PBW Mean±SD Mean±SD Mean±SD Mean±SD
Respiratory rate, mpm Mean±SD Mean±SD Mean±SD Mean±SD
FiO2, % Mean±SD Mean±SD Mean±SD Mean±SD
Static CRS, mL/cmH2O Mean±SD Mean±SD Mean±SD Mean±SD
Dynamic CRS, mL/cmH2O Mean±SD Mean±SD Mean±SD Mean±SD
Use of recruitment manoeuvres
  Increase in PEEP n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  Increase in tidal volume n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  Increase in tidal volume and 
PEEP
n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  Manual insufflation with bag n/Total (%) n/Total (%) n/Total (%) n/Total (%)
  CPAP n/Total (%) n/Total (%) n/Total (%) n/Total (%)
SpO2, % Mean±SD Mean±SD Mean±SD Mean±SD
etCO2, mm Hg Mean±SD Mean±SD Mean±SD Mean±SD
Mean arterial pressure, mm Hg Mean±SD Mean±SD Mean±SD Mean±SD
Heart rate, bpm Mean±SD Mean±SD Mean±SD Mean±SD
Pressure of CO2 insufflation, 
mm Hg
Mean±SD Mean±SD Mean±SD Mean±SD
bpm, beats per minute; CPAP, continuous positive airway pressure; CRS, respiratory system compliance; etCO2, end-tidal carbon dioxide; 
FiO2, fraction of inspired oxygen; mpm, movements per minute; PBW, predicted body weight; PCVG, pressure controlled volume guaranteed; 
PEEP, positive-end expiratory pressure; SpO2, pulse oximetry.
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Cleaning and locking of the database
The database will be locked as soon as all data are entered 
and all discrepant or missing data are resolved—or if all 
efforts are employed and we consider that the remaining 
issues cannot be fixed. At this step, the data will be 
reviewed before database locking. After that, the study 
database will be locked and exported for statistical anal-
ysis. At this stage, permission for access to the database 
will be removed for all investigators and the database will 
be archived.
sample size
All patients submitted to ventilation during general 
anaesthesia for RAS will be consecutively included during 
the period of 1 month, in a convenience sample.
Predefined statistical analysis plan
For the primary analyses, only patients undergoing 
abdominal surgery will be included. Also, patients in 
whom the surgery was converted to open or laparoscopic 
will be excluded. This group of patients excluded due 
to these reasons will be studied in a separate report. 
Continuous distribution of the data will be assessed by 
visual inspection of histograms and D’Agostino-Pearson’s 
normality tests. Baseline characteristics will be expressed 
as counts and percentages, means and SD or medians 
and IQR whenever appropriate. Hypothesis tests will 
be two-sided with a significance level of 5%. We will not 
adjust p values for multiple comparisons. Analyses will 
be performed using the R (R Core Team, 2016, Vienna, 
Austria) programme.
Baseline characteristics
Patients baseline characteristics will be presented as 
shown in mock table 1.
Intraoperative characteristics
Intraoperative characteristics will be presented as shown 
in mock table 2.
Ventilatory variables
Ventilatory variables and other interventions will be 
reported hourly for 6 hours and in four specific periods: 
(1) 5 min after induction and beginning of ventilation 
(T1); (2) 5 min after CO2 insufflation (T2); (3) 5 min after 
definitive positioning (immediately before beginning 
surgery) (T3) and (4) 5 min after removal of pneumo-
peritoneum and return to supine (T4). Peak, plateau and 
driving pressure (defined as plateau minus positive-end 
expiratory pressure (PEEP)) and PEEP levels, tidal 
volume size, respiratory rate, fraction of inspired oxygen 
(FiO2), static and dynamic respiratory system compli-
ance, pulse oximetry (SpO2), heart rate, mean arterial 
pressure and pressure of CO2 insufflation over the four 
specific periods will be analysed using a mixed model 
with repeated measures and plotted in an interaction plot 
(mock table 3).
Primary outcome
The number of patients developing a PPC will be reported 
in absolute numbers and percentages (mock table 4). The 
impact of ventilatory variables on the development of PPC 
will be assessed using a generalised linear mixed-effect 
model. Relevant covariates included in the final multivari-
able model will be identified as those with p<0.2 in the 
univariable model (including centre as a random effect), 
clinical relevance and no statistical association with other 
relevant variables. In the final model, time of measurement 
will be included as a fixed effect together with the variables 
of interest and the centres and patients will be included as 
random effect. The linearity of each continuous predictor 
with the log odds outcome will be checked graphically 
and, if not present, a log-transformation will be performed. 
Pearson correlation coefficients will be used to assess collin-
earity between predictors. Since a high collinearity between 
peak, plateau and driving pressure is expected, the main 
model will consider the variable with the higher amount 
of measurements between peak or plateau pressure. 
Driving pressure will be considered in a sensitivity analysis, 
excluding PEEP, peak and plateau pressure. Finally, the 
intraclass correlation coefficient (ICC) will be assessed. The 
ICC represents the ratio of between-site variance to total 
variance, ranging from 0 to 1.
Table 4 Clinical outcomes
All patients (n=)
Primary outcomes
Postoperative pulmonary complications n/Total (%)
  Unplanned need of oxygen n/Total (%)
  Acute respiratory failure n/Total (%)
  Pneumonia n/Total (%)
  ARDS n/Total (%)
  Pneumothorax n/Total (%)
Secondary outcomes
Severe postoperative pulmonary 
complications
n/Total (%)
Intraoperative complications n/Total (%)
  Desaturation n/Total (%)
  Unplanned recruitment manoeuvres n/Total (%)
  Need for ventilatory pressure reduction n/Total (%)
  Hypotension n/Total (%)
  Need for unplanned vasoactive drug n/Total (%)
  Acute new arrhythmia n/Total (%)
Unplanned ventilation after surgery n/Total (%)
  Reintubation n/Total (%)
New use of mechanical ventilation n/Total (%)
Admission to intensive care unit n/Total (%)
Hospital length of stay Mean±SD
  Median (IQR) Median (IQR)
Hospital mortality n/Total (%)
ARDS, acute respiratory distress syndrome.
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Secondary outcomes
Secondary outcomes will be reported as shown in mock 
table 4.
EthICs And dIssEMInAtIon
The study will be performed according to the national 
and international guidelines. The study will not begin at 
the participating centres until approval has been obtained 
from the local Institutional Review Board for each partic-
ipating centre or country, according to local regulation. 
Prospective written informed consent will be requested 
before inclusion of all eligible patients. The waiver of 
consent will follow local guidelines.
The AVATaR Steering Committee will publish the study 
findings, whatever they are. The main manuscript will 
be submitted by the writing committee on behalf of the 
research group (AVATaR and the PROVENet investiga-
tors). Two to three investigators per centre will be listed 
as collaborators in the online Supplementary appendix in 
alphabetical order according to the name of the centre. 
All efforts will be made to link all collaborators to the 
final publication in indexed databases.
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